Practical Treatment Strategies and Future Directions After Progression While Receiving CDK4/6 Inhibition and Endocrine Therapy in Advanced HR [electronic resource]
Producer: 20210329Description: 1-11 p. digitalISSN:- 1938-0666
- Antineoplastic Agents, Immunological -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Aromatase Inhibitors -- pharmacology
- Biomarkers, Tumor -- genetics
- Biopsy
- Breast -- pathology
- Breast Neoplasms -- genetics
- Chemotherapy, Adjuvant -- methods
- Class I Phosphatidylinositol 3-Kinases -- genetics
- Cyclin-Dependent Kinase 4 -- antagonists & inhibitors
- Cyclin-Dependent Kinase 6 -- antagonists & inhibitors
- Disease Progression
- Drug Resistance, Neoplasm -- genetics
- Female
- Humans
- Mastectomy
- Precision Medicine -- methods
- Progression-Free Survival
- Protein Kinase Inhibitors -- pharmacology
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- genetics
- Receptors, Progesterone -- metabolism
- Selective Estrogen Receptor Modulators -- pharmacology
- Sequence Analysis, DNA
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.